Diphenhydramine Hcl Solution
NDC Package 71741-511-04
Package Information
Diphenhydramine Hcl (diphenhydramine hydrochloride) solution is diphenhydramine injection is an antihistamine used to treat life-threatening allergic reactions (anaphylaxis) along with epinephrine and other treatments. This formulation utilizes a solution delivery system. Marketed by Redmont Pharmaceuticals, Llc, this product is identified by NDC 71741-511 and is authorized under FDA application ANDA087513.
Identification & Billing
- RxCUI: 1049906 - diphenhydrAMINE HCl 12.5 MG in 5 mL Oral Solution
- RxCUI: 1049906 - diphenhydramine hydrochloride 2.5 MG/ML Oral Solution
- RxCUI: 1049906 - diphenhydramine HCl 12.5 MG per 5 ML Oral Solution
- RxCUI: 1049906 - diphenhydramine hydrochloride 25 MG per 10 ML Oral Solution
- RxCUI: 1049906 - diphenhydramine hydrochloride 50 MG per 20 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71741 - Redmont Pharmaceuticals, Llc
- 71741-511 - Diphenhydramine Hcl
- 71741-511-04 - 118 mL in 1 BOTTLE
- 71741-511 - Diphenhydramine Hcl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71741-511-04 identifies a specific commercial package of 118 ml in 1 bottle of Diphenhydramine Hcl, a human prescription drug labeled by Redmont Pharmaceuticals, Llc. This product is billed per "ML" milliliter and contains an estimated amount of 118 billable units per package. This solution is formulated for oral use and contains diphenhydramine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Redmont Pharmaceuticals, Llc on July 22, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Diphenhydramine injection is an antihistamine used to treat life-threatening allergic reactions (anaphylaxis) along with epinephrine and other treatments. It is also used to relieve symptoms of household allergies, hay fever and the common cold when medication cannot be given by mouth. Common allergy symptoms relieved by antihistamines include rash, itching, watery eyes, itchy eyes/nose/throat, cough, runny nose and sneezing. It is also used to treat nausea, vomiting and dizziness caused by motion sickness when medication cannot be given by mouth. Diphenhydramine works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Its drying effects on such symptoms as watery eyes and runny nose are caused by blocking another natural substance made by your body (acetylcholine). Diphenhydramine should not be used in newborns or premature infants because of an increased risk of side effects. It should not be used for common cold symptoms in children less than 6 years of age due to the risk of serious side effects, such as slow/shallow breathing. Cough-and-cold products have not been shown to be safe or effective in children younger than 6.
How is this Redmont Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71741051104. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 118 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.